Century Therapeutics Tapped Morgan Conn Of Pharvaris as CFO, Effective Oct 14
Portfolio Pulse from Benzinga Newsdesk
Century Therapeutics, Inc. (NASDAQ:IPSC) has appointed Morgan Conn, Ph.D., as CFO and Chad Cowan, Ph.D., as CSO, effective October 2024. Conn brings extensive biopharma finance and business development experience, previously serving as Chief Business Officer at Pharvaris.
September 26, 2024 | 11:07 am
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Century Therapeutics has appointed Morgan Conn as CFO, bringing significant biopharma finance and business development experience. This leadership change could positively impact the company's strategic direction and investor confidence.
The appointment of a new CFO with extensive experience in biopharma finance and business development is likely to positively influence Century Therapeutics' strategic initiatives and investor relations. This could lead to increased investor confidence and potential stock price appreciation.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100